{"id":"W4406224144","doi":"10.1002/alz.084521","title":"Single ascending dose results from an ongoing Phase 1 study of mivelsiran (ALN‐APP), the first investigational RNA interference therapeutic targeting amyloid precursor protein for Alzheimer’s disease","year":2024,"lang":"en","type":"article","venue":"Alzheimer s & Dementia","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"","keywords":"RNA interference; Amyloid precursor protein; Disease; Medicine; Alzheimer's disease; Amyloid (mycology); Amyloid β; Investigational Drugs; Cancer research; RNA; Oncology; Biology; Internal medicine; Pathology; Gene; Genetics; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00200432,0.001193841,0.001997638,0.0003440526,0.0003700227,0.0006977717,0.0007149404,0.0009257848,0.003934852],"category_scores_gemma":[0.001317664,0.0004688015,0.001272722,0.0003213327,0.0006664552,0.0007984461,0.0002497289,0.002181132,0.0008274891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000587021,"about_ca_system_score_gemma":0.001061823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000696859,"about_ca_topic_score_gemma":0.001572713,"domain_scores_codex":[0.9992551,0.0003492329,0.00006205657,0.0001251909,0.00009603328,0.000112336],"domain_scores_gemma":[0.9990327,0.0002319708,0.0002346756,0.00009984191,0.0001097407,0.000291042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8026603,0.06481069,0.003345716,0.0006878221,0.001540329,0.000180162,0.0002023746,0.001379034,0.072503,0.0001604931,0.002949224,0.04958087],"study_design_scores_gemma":[0.3158972,0.6527226,0.01328011,0.00003341521,0.001292958,0.0002091417,0.00006535583,0.0008763511,0.01277391,0.0002263663,0.002578364,0.00004429457],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918909,0.002110026,0.0007003983,0.0001713049,0.0001023017,0.001633625,0.001720408,0.00007171297,0.001599392],"genre_scores_gemma":[0.9894121,0.00126631,0.001635216,0.0003953117,0.0001263894,0.001855955,0.003156309,0.00002961797,0.002122798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003934852,"threshold_uncertainty_score":0.01316345,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08557850934553687,"score_gpt":0.3496156370631333,"score_spread":0.2640371277175965,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}